» Articles » PMID: 35054906

COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 21
PMID 35054906
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 is a trending topic worldwide due to its immense impact on society. Recent trends have shifted from acute effects towards the long-term morbidity of COVID-19. In this review, we hypothesize that SARS-CoV-2 contributes to age-related perturbations in endothelial and adipose tissue, which are known to characterize the early aging process. This would explain the long-lasting symptoms of SARS-CoV-2 as the result of an accelerated aging process. Connective tissues such as adipose tissue and musculoskeletal tissue are the primary sites of aging. Therefore, current literature was analyzed focusing on the musculoskeletal symptoms in COVID-19 patients. Hypovitaminosis D, increased fragility, and calcium deficiency point towards bone aging, while joint and muscle pain are typical for joint and muscle aging, respectively. These characteristics could be classified as early osteoarthritis-like phenotype. Exploration of the impact of SARS-CoV-2 and osteoarthritis on endothelial and adipose tissue, as well as neuronal function, showed similar perturbations. At a molecular level, this could be attributed to the angiotensin-converting enzyme 2 expression, renin-angiotensin system dysfunction, and inflammation. Finally, the influence of the nicotinic cholinergic system is being evaluated as a new treatment strategy. This is combined with the current knowledge of musculoskeletal aging to pave the road towards the treatment of long-term COVID-19.

Citing Articles

The mediating role of physical activity and quality of life in the association between knee osteoarthritis-related symptoms and physical function of post-COVID patients in Metro Manila: a study protocol.

Manlapaz D, Rivero J, Cabildo E, Advincula J, Aquino M, De la Paz M BMJ Open. 2025; 15(1):e088650.

PMID: 39855653 PMC: 11758699. DOI: 10.1136/bmjopen-2024-088650.


Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis.

Zheng X, Li J, Ma Q, Gong J, Pan J BMC Med Genomics. 2025; 18(1):2.

PMID: 39748395 PMC: 11697936. DOI: 10.1186/s12920-024-02074-4.


Advance in the mechanism and clinical research of myalgia in long COVID.

Zhai X, Wu W, Zeng S, Miao Y Am J Clin Exp Immunol. 2024; 13(4):142-164.

PMID: 39310121 PMC: 11411160. DOI: 10.62347/TXVO6284.


Bioinformatics and system biology approach to identify potential common pathogenesis for COVID-19 infection and sarcopenia.

Zhong J, Yuan H, Yang J, Du Y, Li Z, Liu X Front Med (Lausanne). 2024; 11:1378846.

PMID: 38978778 PMC: 11228343. DOI: 10.3389/fmed.2024.1378846.


Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement.

Gusev E, Sarapultsev A Int J Mol Sci. 2024; 25(12).

PMID: 38928096 PMC: 11204317. DOI: 10.3390/ijms25126389.


References
1.
Di Filippo L, Doga M, Frara S, Giustina A . Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord. 2021; 23(2):299-308. PMC: 8041474. DOI: 10.1007/s11154-021-09655-z. View

2.
Syx D, Tran P, Miller R, Malfait A . Peripheral Mechanisms Contributing to Osteoarthritis Pain. Curr Rheumatol Rep. 2018; 20(2):9. PMC: 6599517. DOI: 10.1007/s11926-018-0716-6. View

3.
McFarland A, Yousuf M, Shiers S, Price T . Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep. 2021; 6(1):e885. PMC: 7803673. DOI: 10.1097/PR9.0000000000000885. View

4.
Al Heialy S, Hachim M, Senok A, Gaudet M, Abou Tayoun A, Hamoudi R . Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19. Front Physiol. 2020; 11:555039. PMC: 7531362. DOI: 10.3389/fphys.2020.555039. View

5.
Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Pere H . Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Sci Rep. 2021; 11(1):11886. PMC: 8178312. DOI: 10.1038/s41598-021-91417-7. View